Association of Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) with Mortality in Patients with Coronavirus Disease 2019 (COVID-19) in Fatmawati General Hospital: A Preliminary Data

Authors

  • Nikko Darnindro Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • M Ikhsan Mokoagow Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Annela Manurung Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Jerry Nasarudin Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Elisabeth Yasmine Wardoyo Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Anggraini Permata Sari Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Aryan Yohanes Djojo Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Martha Iskandar Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Giri Aji Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Radhiyatam Mardiyah Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Nadya Magfira Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Marina Epriliawati Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Edi Mulyana Department of Internal Medicine, Fatmawati General Hospital, Jakarta
  • Arnold Harahap Department of Internal Medicine, Fatmawati General Hospital, Jakarta

DOI:

https://doi.org/10.24871/212202089-94

Keywords:

Aspartate aminotransferase (AST), alanine aminotransferase (ALT), COVID-19, mortality

Abstract

Background: COVID-19, caused by SARS-CoV-2 virus, is a novel disease that has not been previously identified. The disease may result in multiple organ impairment leading to death. Liver is also affected by this viral infection. This study aimed to investigate the association of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) with mortality rate in these patients.

Method: This is a retrospective cohort study of COVID-19 patients admitted in Fatmawati General Hospital during a period of March-April, 2020. Diagnosis of COVID-19 was established from real time Polymerase chain reaction (RT PCR). Association of AST and ALT levels with mortality was analyzed by using SPSS® version 16.0.

Results: Forty-two patients were diagnosed as confirmed case of COVID-19, 52.3% of them were male. Mean age was 54.6±12 years. Median (IQR) value of AST and ALT levels were 55(48) U/L and 39(40) U/L, respectively. AST and ALT was elevated in 71.4% and 42.9%, respectively. Increased levels of AST and ALT  2 times above the upper normal limit (UNL), >2 times ULN, and > 5 times ULN were found in 33.3% and 21.4%;  38.1% and 21.4%; 4.8% and 4.8%, respectively. Mortality was recorded in 45.1% of these confirmed cases, 50% occurred within 2 days of hospitalization. Higher mean value of AST is associated with an increased mortality risk (101 ± 147 U/L vs. 82.78 ± 173 U/L; p 0.032). Sub-analysis identified that abnormal AST >2 times above UNL has a higher mortality proportion compared with AST  2 times UNL and normal AST levels (62.5% vs. 50% vs. 16.7%; p 0.05). Mean value of ALT is not associated with mortality (p 0.479). Further sub-analysis found that in patients who succumbed to the disease, abnormal levels of AST and ALT is related to the time of death during hospitalization despite being statistically not significant.

Conclusion: Mortality rate of COVID-19 in hospitalized patients remains high. Increased AST levels was significantly associated with higher mortality rate. This finding merit further investigation by incorporating larger sample size to discern the role of these factors’ contribution to mortality in COVID-19.

 

Downloads

Published

2020-09-30

How to Cite

Darnindro, N., Mokoagow, M. I., Manurung, A., Nasarudin, J., Wardoyo, E. Y., Sari, A. P., … Harahap, A. (2020). Association of Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) with Mortality in Patients with Coronavirus Disease 2019 (COVID-19) in Fatmawati General Hospital: A Preliminary Data. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy, 21(2), 89–94. https://doi.org/10.24871/212202089-94

Issue

Vol. 21 No. 2 (2020): VOLUME 21, NUMBER 2, August 2020

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).